Xchanging Plc Shares Surge 10% After CSC Trumps Capita PLC’s Bid

A new bid for Xchanging Plc (LON: XCH) has sent its shares soaring, while endorsement for Capita PLC’s (LON: CPI) bid has been withdrawn.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in insurance software specialist Xchanging (LSE: XCH) are up by 10% today after a dramatic late bid by Computer Sciences Corporation (CSC) was unanimously recommended by the company’s board.

The new 190p per share offer is almost 19% higher than the previously recommended bid by Capita (LSE: CPI) which has now been overlooked in favour of CSC’s, despite around 25% of Xchanging’s shareholders having already accepted the lower offer. They will, of course, have the opportunity to change their minds and accept the higher bid.

Is that the end of the story? Not at all. While CSC’s bid is said to have gained support from 47% of Xchanging’s shareholders, there’s still a chance of further developments later on today. That’s because a third company, Ebix, has until close of business today to make a formal offer, while Capita’s bid was said to be final when it was originally made.

Clearly, Xchanging is an in-demand company at the present time. And looking at its growth prospects it’s easy to see why. The company’s earnings per share may be set to fall by 30% in the current financial year but there are better times ahead. Looking ahead to next year, its bottom line is set to rise by 36%.

With shares in the company trading on a price-to-earnings (P/E) ratio of 23.3, this equates to a price-to-earnings growth (PEG) ratio of just 0.6. This indicates that the company’s shares are relatively good value for money even at their current price of 193p. And even though investor sentiment had been weak prior to the initial bid approach from Capita in August, improved performance in the next financial year could have acted as a positive catalyst over the medium term.

Of course, Xchanging’s real appeal today appears to be centred on the potential synergies that could be created in combination with CSC. That company has said it believes that Xchanging’s capabilities and experience in the commercial insurance market would complement its own global insurance presence in the software, outsourcing and services spaces.

Notably, Xchanging’s new Xuber offering has been relatively successful in terms of its adoption among UK-based insurers and while the company has attempted to diversify in recent years, its core activities remain relatively appealing to its peers. As a result, it’s perhaps unsurprising that Xchanging has become the subject of an apparent bid war.

With Xchanging’s shares trading above the 190p per share cash offer from CSC, it appears as though the market may be pricing in a further, higher bid. While this prospect could entice investors seeking to make a quick gain, the reality is that it’s impossible to determine whether there will be any further bids. Therefore, buying at a higher price than the current highest offer (which has been recommended by Xchanging’s board) doesn’t appear to be a sound move.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

10%+ dividend growth! 2 FTSE 250 shares tipped to turbocharge dividends

These FTSE 250 income shares look in great shape to grow their dividends by double-digit percentages, says our writer Royston…

Read more »

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Investing Articles

Would it be madness to buy this FTSE stock smashed by Donald Trump’s team picks?

Ben McPoland takes a look at one FTSE share inside his portfolio that has been battered lately due to a…

Read more »

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »